Author

Devie Deland

Observed names: D Deland, Deland, D.

Institutions: Memorial Sloan Kettering Cancer Center, Ludwig Cancer Research

Observed institutions: Memorial Sloan Kettering Cancer Center, Ludwig Cancer Research

OpenAlex ID: A5023679883

Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma.

1998 · C R Divgi, N H Bander, et al. · PubMed · 158

Hematologic Toxicity in Radioimmunotherapy: Dose-Response Relationships for I-131 Labeled Antibody Therapy

2002 · Joseph A. O'Donoghue, Nanaefua Baidoo, et al. · Cancer Biotherapy and Radiopharmaceuticals · 55

Pharmacokinetic model of iodine-131-G250 antibody in renal cell carcinoma patients.

1998 · A Loh, G Sgouros, et al. · PubMed · 10

Works count: 5

Citation count: 223

H-index: 3

I10-index: 3